Abstract
Context The spread of SARS-CoV-2 led to a rapid and deadly pandemic which reached almost all countries in the world in a few months. In most countries, rigorous measures of mitigation, including national or subnational lockdowns were established. The present work aimed at quantifying the effect of national lockdown in France on hospital occupancy.
Methods A compartmental model describing patient hospital flows was developed, where the effect of lockdown was quantified on the hospitalization rate. Model parameters were estimated using nonlinear mixed-effects (NLME) modelling.
Results French lockdown led to a hospitalization rate decreased by thrice from 12 days after its beginning. However, lockdown may not to have decreased either hospital occupancy or deaths in hospital, which would have been both decreased by 30% and 85% in average if lockdown was started 20 and 30 days before this date, respectively.
Conclusion The present work showed an intrinsic effect of lockdown to decrease hospital burden, but its efficacy on hospital burden may have been increased if established sooner.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
These data are public data, obtained in official sites.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos